Korea Exchange Finds GeneOne Life Science Meets Delisting Criteria
The Korea Exchange’s corporate review committee determined on Oct. 29, 2026, that GeneOne Life Science meets the delisting criteria. The company is delisted.
Related stories
U.S. Sues Google Over Former Employee’s Return From Military Deployment
The U.S. sued Google, alleging it failed to restore a former employee to a similar job after his military deployment.
L impact | REGULATION | Oct 29, 2026, 03:16 PM UTC
FCC Votes to Proceed With New Spectrum Auction for Direct-to-Device Services
The FCC voted to proceed with a new radio spectrum auction intended to strengthen direct-to-device services.
L impact | REGULATION | Oct 29, 2026, 03:09 PM UTC
FCC Votes to Hold New Spectrum Auction for Direct-to-Device Services
The FCC voted in favor of holding a new spectrum auction to support direct-to-device services.
M impact | REGULATION | Oct 29, 2026, 03:09 PM UTC
FCC Moves Forward With New Spectrum Auction for Direct-to-Device Services
The FCC decided to advance a new spectrum auction intended to promote direct-to-device services.
L impact | REGULATION | Oct 29, 2026, 03:08 PM UTC
FCC Approves Plan to Hold New Spectrum Auction
The U.S. Federal Communications Commission approved pursuing a new spectrum auction to support direct-to-device services.
L impact | REGULATION | Oct 29, 2026, 03:07 PM UTC
FCC votes to advance new spectrum auction for direct-to-device services
The Federal Communications Commission voted to advance a new wireless spectrum auction to promote direct-to-device services.
L impact | REGULATION | Oct 29, 2026, 03:07 PM UTC